首页> 外文期刊>Clinical proteomics. >Clinical proteomics of enervated neurons
【24h】

Clinical proteomics of enervated neurons

机译:沟通神经元的临床蛋白质组学

获取原文
获取原文并翻译 | 示例
           

摘要

The dynamic field of neurosciences entails ever increasing search for molecular mechanisms of disease states, especially in the domain of neurodegenerative disorders. The previous century heralded the techniques in proteomics when indexing of the human proteomes relating to various disease conditions became important. Early stage research in certain diseases or pathological conditions requires a more holistic approach of first discovering the proteins of interest for the condition. Despite its limitations, proteomics is one of the most powerful techniques available to us today to dissect the molecular scenario in a particular disease situation. In this review we will discuss about the current clinical research in neurodegenerative disorders that employ proteomics techniques. We will specifically focus on our understanding of Alzheimer's disease, traumatic spinal cord injury and neuromyelitis optica. Discussions will include ongoing worldwide research in these areas, research in India and specifically our laboratory in these domains of neurodegenerative conditions. The most polarized cells of the human body, neurons, are a specialized type with respect to their functional properties. Development and function of neurons are closely linked to the bidirectional transport of molecules from the synaptic end to the cell body. This very synaptic signal, which when disrupted, causes the dysfunction of neuronal activities. Disruption in axonal transport is the cause of several neurodegenerative disorders [1, 2]. In the realm of peripheral neuron injury, retrograde transport of molecules from the site of injury to the cell body of a peripheral neuron primes the latter to regenerate [3, 4]. This phenomenon is absent in the central nervous system (CNS), with the consequence of regeneration after CNS injury being elusive even with years of research. Partly because of the large distance separating the axon end from the cell body, many molecular events after a trauma or a neuronal disease occur without any transcriptional manifestations [5]. Local proteolysis, protein synthesis and post translational modifications are the key to understanding axonal events after an assault or a disorder of the neuron [5]. Proteomics approaches have therefore come to the limelight in recent times. In this review, we will discuss the contributions of our group from this perspective and also the prospective ideas in three neurological degenerative situations, namely Alzheimer's disease (AD), traumatic spinal cord injury (SCI) and neuromyelitis optica (NMO) and explore the advances in understanding these pathological processes using proteomics approaches.
机译:神经科学的动态领域需要增加疾病状态的分子机制,特别是在神经变性障碍的结构领域。前世纪预示着蛋白质组学中的技术,当与各种疾病条件相关的人类蛋白质素变得重要。在某些疾病或病理条件下的早期研究需要更加全面的方法,首先发现该病症的蛋白质。尽管有其局限性,蛋白质组学是当今我们可用的最强大的技术之一,以将分子情景分析在特定疾病情况下。在这篇审查中,我们将讨论雇用蛋白质组学技术的神经变性障碍目前的临床研究。我们将专门关注我们对阿尔茨海默病,创伤脊髓损伤和神经髓炎OPTICA的理解。讨论将包括在这些领域的持续研究,印度研究,特别是我们在这些神经变性条件的域中的实验室。人体的最偏振细胞神经元是一种相对于其功能性的专用类型。神经元的开发和功能与来自突触端到细胞体的分子的双向传输密切相关。这种非常突触信号发生在中断时,导致神经元活动功能障碍。轴突运输中断是几种神经变性障碍的原因[1,2]。在外周神经元损伤的领域中,从损伤部位对外周神经元的细胞体逆行分子传输后者再生[3,4]。在中枢神经系统(CNS)中,这种现象不存在于CNS损伤后的再生后,即使是多年的研究。部分是因为大距离从细胞体分离轴突,在没有任何转录表现的情况下发生创伤或神经元疾病后的许多分子事件[5]。局部蛋白水解,蛋白质合成和翻译后修改是了解攻击后轴突事件或神经元的疾病[5]的关键。因此,蛋白质组学方法近期来到敏捷。在这篇综述中,我们将从这种观点讨论我们的小组的贡献以及三种神经退行性情况的前瞻性思想,即阿尔茨海默病(AD),创伤性脊髓损伤(SCI)和神经髓炎OPTICA(NMO)并探索进步在理解这些病理过程中使用蛋白质组学方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号